Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccination

View ORCID ProfileEmily J. Ciccone, View ORCID ProfileDeanna R. Zhu, View ORCID ProfileRawan Ajeen, Evans K. Lodge, View ORCID ProfileBonnie E. Shook-Sa, View ORCID ProfileRoss M. Boyce, View ORCID ProfileAllison E. Aiello, COVID HCP Study Team
doi: https://doi.org/10.1101/2021.02.09.21251319
Emily J. Ciccone
1Division of Infectious Diseases, School of Medicine, University of North Carolina
MD, MHS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily J. Ciccone
Deanna R. Zhu
2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deanna R. Zhu
Rawan Ajeen
2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
BSPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rawan Ajeen
Evans K. Lodge
2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
BA, BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie E. Shook-Sa
3Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina
DrPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bonnie E. Shook-Sa
Ross M. Boyce
1Division of Infectious Diseases, School of Medicine, University of North Carolina
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ross M. Boyce
Allison E. Aiello
2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina
PhD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allison E. Aiello
  • For correspondence: aaiello@email.unc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The effect of SARS-CoV-2 infection on response to mRNA-based SARS-CoV-2 vaccines is not well-described. We assessed longitudinal SARS-CoV-2-specific antibody responses pre- and post-vaccination among individuals with and without prior infection. The antibody response to the first vaccine dose was almost two-fold higher in individuals who were seropositive before vaccination compared to those who were seronegative, suggesting that prior infection primes the immune response to the first dose of mRNA-based vaccine.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://preprints.jmir.org/preprint/25410

Funding Statement

This study was supported by funds from the following sources: 1. 2007 Gillings Gift at the UNC Gillings School of Global Public Health (AEA) 2. North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly (EJC, RMB, RA, DRZ) 3. UNC School of Medicine (RMB) 4. A generous donation to the UNC School of Medicine by an anonymous donor (RMB) 5. National Institute of Occupational Safety and Health through Grant Award Number [75D30121P10086 0000HCCK-2021] (AEA, EJC) 6. National Science Foundation through Grant Award Number NSF 20-4353 (AEA) 7. National Institutes of Health through Grant Award Number R01 EB0225021 (AEA) 8. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001111 supported the use of the REDCap database. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. In addition, EJC is supported by the National Heart, Lung, and Blood Institute through Grant Award Number [5T32HL007106-43], RMB is supported by the National Institute of Allergy and Infectious Diseases through Grant Award Number [5K23AI141764-03], and BES is supported by the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI050410. The funding organizations/sponsors were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of North Carolina Institutional Review Board #20-0942

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • 1. New data points became available and were added. Figure 1 and the corresponding manuscript text were updated accordingly. The additional data did not change the findings of the study. 2. A supplementary figure was added that shows SARS-CoV-2-specific antibody responses by days from first (Panel a) and second (Panel b) vaccination. 3. Evans K. Lodge was added as an author. 4. Additional citations were added. 5. A statement was added regarding ethics review and informed consent. 6. The last paragraph was updated to clarify our interpretation of the study results. 7. We reformatted for journal specifications and made general editorial changes to the manuscript.

Data Availability

The study described in this manuscript is ongoing, and therefore, the data are not yet available to others. Once study follow-up is completed, the data will be made available by request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccination
Emily J. Ciccone, Deanna R. Zhu, Rawan Ajeen, Evans K. Lodge, Bonnie E. Shook-Sa, Ross M. Boyce, Allison E. Aiello, COVID HCP Study Team
medRxiv 2021.02.09.21251319; doi: https://doi.org/10.1101/2021.02.09.21251319
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccination
Emily J. Ciccone, Deanna R. Zhu, Rawan Ajeen, Evans K. Lodge, Bonnie E. Shook-Sa, Ross M. Boyce, Allison E. Aiello, COVID HCP Study Team
medRxiv 2021.02.09.21251319; doi: https://doi.org/10.1101/2021.02.09.21251319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (139)
  • Cardiovascular Medicine (1946)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (699)
  • Epidemiology (11102)
  • Forensic Medicine (8)
  • Gastroenterology (624)
  • Genetic and Genomic Medicine (3168)
  • Geriatric Medicine (308)
  • Health Economics (561)
  • Health Informatics (2042)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12720)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2986)
  • Nursing (164)
  • Nutrition (463)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1552)
  • Ophthalmology (477)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (912)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2784)
  • Public and Global Health (5591)
  • Radiology and Imaging (1093)
  • Rehabilitation Medicine and Physical Therapy (634)
  • Respiratory Medicine (759)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (132)